Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Tokyo  >  Terumo Corp    4543   JP3546800008

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets

Terumo : Expands Production in Asia New Factory Established and Existing Facilities Expanded in Vietnam and the Philippines

share with twitter share with LinkedIn share with facebook
share via e-mail
05/10/2012 | 08:13am CET
May 10, 2012

Terumo Corporation (TOKYO:4543) announced today that it will expand its production facilities in Asia to meet anticipated sales increases in the medium to long term, based on its corporate growth strategy. Terumo Corporation will establish a new factory in Vietnam, its second in the country, as well as expand the production scale of existing factories in Vietnam and the Philippines. The total amount invested will be 15 billion yen.

The new factory in Vietnam will produce blood management products such as blood bags to meet growing global demand, especially in emerging countries.
In cooperation with Ashitaka factory (Shizuoka prefecture) and the new Yamaguchi factory in Japan (operation to be started in 2015), the existing factory in Vietnam will expand the production scale of interventional systems products, sales of which have been growing at a double-digit pace. The company will also establish a new production building at the existing factory in the Philippines to cope with needed production increases of syringes and needles.
To improve its global competitiveness, Terumo Corporation is seeking to enhance the production capacity across all of its three business areas: Cardiac & Vascular, General Hospital, and Blood Management.

Terumo Corporation's global production system

Terumo Corporation is accelerating its growth globally, and plans to increase the percent of production done outside Japan in line with the growth in the share of net sales outside Japan, which already account for over half of the total. Accordingly, the company has positioned factories in Asia as its global production center and is already producing a broad range of products in China, the Philippines, and Vietnam.
On another front, certain highly advanced and precise production technologies are difficult to transfer outside of Japan. The company has designated factories in Japan as mother production factories that develop and refine core manufacturing technologies to underpin product improvement.
Terumo Corporation will continue to enhance its global production system in factories in Asia and Japan to meet growing global demand while increasing cost competitiveness.

Factories Overview 1. Vietnam: a new factory to be established

In April 2012, Terumo BCT was established through the integration of CaridianBCT and Terumo Transfusion, following Terumo Corporation's acquisition of CaridianBCT in April 2011. The company will establish a new factory in Vietnam to produce blood management products to meet growing global demand, especially in emerging countries. The factory will be its sixth production facilities of blood management products, following ones in Japan, U.S., UK

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on TERUMO CORP
11/09 TERUMO : Revises Upward Interim Dividends and Year-End Dividends Forecast for th..
10/24 GLOBAL PERIPHERAL GUIDEWIRE MARKET T : Some of the key participants in this mark..
10/19 TERUMO : Revises the First-Half Results Forecast for FY 2017
10/10 TECH MAHINDRA : To set up odc for terumo bct
10/10 TERUMO : Provides Update on Impact from Hurricane Maria
09/29 TERUMO : Federal Contracts Awarded by Federal Agencies in Hawaii (Sept. 29)
09/29 TERUMO : $479,000 Federal Contract Awarded to Terumo Cardiovascular Systems
09/29 TERUMO : MILITARY $17.28 Million Federal Contract Awarded to Terumo Biotechnolog..
09/28 TERUMO : Opens a New Innovation Center in Southern California
09/27 TERUMO : MILITARY $26,829 Federal Contract Awarded to Terumo BCT
More news
News from SeekingAlpha
10/27 HAEMONETICS : Revisiting The Company's Outlook
2016 HAEMONETICS : Investor Patience Is Wearing Thin
2016 Terumo Corp. ADR 2017 Q2 - Results - Earnings Call Slides
2016 Abbott's Vascular Products Sale Likely Done To Address Regulatory Concerns
2016 Abbott's Vascular Tech Is Big In Japan
Financials ( JPY)
Sales 2018 579 B
EBIT 2018 -
Net income 2018 57 378 M
Debt 2018 191 B
Yield 2018 0,93%
P/E ratio 2018 30,73
P/E ratio 2019 27,74
EV / Sales 2018 3,62x
EV / Sales 2019 3,37x
Capitalization 1 903 B
Duration : Period :
Terumo Corp Technical Analysis Chart | 4543 | JP3546800008 | 4-Traders
Technical analysis trends TERUMO CORP
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 5 145  JPY
Spread / Average Target 2,7%
EPS Revisions
Shinjiro Sato President, CEO & Representative Director
Takayoshi Mimura Chairman
Ryo Nishihata Chief Accounting & Financial Officer
Hiroaki Kasukawa CTO, Executive Officer, GM-Research & Development
Katsuya Takeuchi Executive Officer & Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
TERUMO CORP15.84%16 971
MEDTRONIC PLC11.60%111 971
C R BARD INC48.47%24 540